Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.550NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.261NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.3.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EP.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.15.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XCBNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.15.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CM.8.1.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XSNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.4.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.29NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.38NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.40NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.160.25NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.74NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.2.6.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.238NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.11NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.68NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.7.26NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BR.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.25NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.51NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FT.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.2.11.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.468NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-21194.8China
AY.131 (Delta)NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-21194.8China
B.1.167NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-21180.6Germany
B.1.494ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.167ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.267ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.165ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.554ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.243.2ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
A.2.5.3ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.450ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
AY.130ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.444ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
AW.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.268ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.344ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.103ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.485ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.119ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.276ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.1.111ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used